These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36479303)

  • 1. Ferric Carboxymaltose in the Management of Iron Deficiency Anemia in Pregnancy: A Subgroup Analysis of a Multicenter Real-World Study Involving 1191 Pregnant Women.
    Trivedi P; Chitra S; Natarajan S; Amin V; Sud S; Vyas P; Singla M; Rodge A; Swami OC
    Obstet Gynecol Int; 2022; 2022():5759740. PubMed ID: 36479303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Ferric Carboxymaltose in the Management of Iron Deficiency Anemia: A Multi-Center Real-World Study from India.
    Charmila A; Natarajan S; Chitra TV; Pawar N; Kinjawadekar S; Firke Y; Murugesan U; Yadav P; Ohri N; Modgil V; Rodge A; Swami OC
    J Blood Med; 2022; 13():303-313. PubMed ID: 35706850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy.
    Khalafallah AA; Hyppa A; Chuang A; Hanna F; Wilson E; Kwok C; Yan C; Gray Z; Mathew R; Falloon P; Dennis A; Pavlov T; Allen JC
    Semin Hematol; 2018 Oct; 55(4):223-234. PubMed ID: 30502851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron-deficiency Anemia Treatment with Ferric Carboxymaltose: A Real-world Quasi-experimental Study from Bangladesh.
    Miah MMZ; Pramanik MEA; Rafi A; Akhter M
    Euroasian J Hepatogastroenterol; 2024; 14(1):12-15. PubMed ID: 39022215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. REGAIN STUDY: Retrospective Study to Assess the Effectiveness, Tolerability, and Safety of Ferric Carboxymaltose in the Management of Iron Deficiency Anemia in Pregnant Women.
    Wani S; Noushad M; Ashiq S
    Anemia; 2019; 2019():4640635. PubMed ID: 31781389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effects and safety of ferric carboxymaltose in pregnancy: An Indian real-life experience.
    Gupte SA; Venkataraman G; Shah AS; Mudholkar AS; Jangam SM
    J Obstet Gynaecol Res; 2021 Oct; 47(10):3464-3470. PubMed ID: 34342089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferric carboxymaltose for treatment of iron deficiency and iron deficiency anemia caused by abnormal uterine bleeding.
    Hagras AM; Hussein NA; Abdelazim I; Elhamamy N
    Prz Menopauzalny; 2022 Dec; 21(4):223-228. PubMed ID: 36704761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous ferric carboxymaltose rapidly increases haemoglobin and serum ferritin among pregnant females with moderate-to-severe anaemia: A single-arm, open-label trial.
    Kant S; Haldar P; Malhotra S; Kaur R; Rath R; Jacob OM
    Natl Med J India; 2020; 33(6):324-328. PubMed ID: 34341207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean women.
    Shim JY; Kim MY; Kim YJ; Lee Y; Lee JJ; Jun JK; Shin JC; Cho YK; Lee KY; Kim A; Song TB
    BMC Pregnancy Childbirth; 2018 Aug; 18(1):349. PubMed ID: 30153811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of ferric carboxy maltose in treatment of iron deficiency/iron deficiency anaemia during pregnancy.
    Obaid M; Abdelazim IA; AbuFaza M; Al-Khatlan HS; Al-Tuhoo AM; Alkhaldi FH
    Prz Menopauzalny; 2023 Mar; 22(1):16-20. PubMed ID: 37206681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics and safety of ferric carboxymaltose: a multiple-dose study in patients with iron-deficiency anaemia secondary to a gastrointestinal disorder.
    Geisser P; Rumyantsev V
    Arzneimittelforschung; 2010; 60(6a):373-85. PubMed ID: 20648929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP).
    Breymann C; Milman N; Mezzacasa A; Bernard R; Dudenhausen J;
    J Perinat Med; 2017 May; 45(4):443-453. PubMed ID: 27278921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients --A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose.
    Schatz U; Illigens BM; Siepmann T; Arneth B; Siegert G; Siegels D; Heigl F; Hettich R; Ramlow W; Prophet H; Bornstein SR; Julius U
    Atheroscler Suppl; 2015 May; 18():199-208. PubMed ID: 25936327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomised Controlled Trial to Compare Injection Ferric Carboxymaltose and Oral Iron in Treating Iron Deficiency Anemia During Pregnancy.
    Chawla S; Singh A; Jhamb D; Anupama CH
    J Obstet Gynaecol India; 2022 Dec; 72(6):492-496. PubMed ID: 36506904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia.
    Geisser P; Banké-Bochita J
    Arzneimittelforschung; 2010; 60(6a):362-72. PubMed ID: 20648928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved Hemoglobin Response with Ferric Carboxymaltose in Patients with Gastrointestinal-Related Iron-Deficiency Anemia Versus Oral Iron.
    Lichtenstein GR; Onken JE
    Dig Dis Sci; 2018 Nov; 63(11):3009-3019. PubMed ID: 30056562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous ferric carboxymaltose for anaemia in pregnancy.
    Froessler B; Collingwood J; Hodyl NA; Dekker G
    BMC Pregnancy Childbirth; 2014 Mar; 14():115. PubMed ID: 24667031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications.
    Bailie GR
    Arzneimittelforschung; 2010; 60(6a):386-98. PubMed ID: 20648930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of ferric carboxymaltose for treatment of iron deficiency anemia diagnosed in the third trimester of pregnancy: A case-control study.
    Busnelli A; Fabiani C; Acerboni S; Moretti Montefusco S; Di Simone N; Setti PEL; Bulfoni A
    J Obstet Gynaecol Res; 2023 Apr; 49(4):1161-1166. PubMed ID: 36658740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron Deficiency Anemia with Menorrhagia: Ferric Carboxymaltose a Safer Alternative to Blood Transfusion.
    Mishra V; Verneker R; Gandhi K; Choudhary S; Lamba S
    J Midlife Health; 2018; 9(2):92-96. PubMed ID: 29962808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.